Search

Copyright of Journal of Dalian University of Technology / Dalian Ligong Daxue Xuebao is the property of Journal of Dalian University of Technology and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

An equal-strength cantilever beam sensor based on the multi-layer ionic skin (flexible capacitance sensor chips) was designed and prepared, to solve the problem that most existing thin-film-structure flexible sensors cannot simultaneously measure concentrated normal forces and displacements. The proposed sensor is comprised of the multi-layer ionic skin and the equal-strength cantilever beam. The normal contact forces or displacements can be acquired through measurement of the capacitance change of the sensor, with the free end of the beam contacting the measured object. A theoretical sensing model of the relationship between capacitance change and force/displacement was established and then verified through displacement/force loading tests. The test results show that, the sensing model is in good agreement with the test data. For the measurement of force and displacement, the sensitivity of the sensor with a 4-layer structure is 1.855 mN/pF and 0.694 mm/pF, respectively. The minimum measurable force is 0.02 mN and the minimum measurable displacement is 0.01 mm. At the same time, the sensor shows good linearity (R² = 0.994). This sensing model provides a theoretical basis for the design of such sensors with good application prospects in the fields of flexible machines and medical health detection. [ABSTRACT FROM AUTHOR]

Copyright of Science Technology & Engineering is the property of Chinese Society of Technology Economics and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

The effectiveness of a palatal augmentation prosthesis(PAP)for dysarthria and dysphagia in patients with amyotrophic lateral sclerosis (ALS) has been reported. However, it is challenging to decide on the intervention of PAP therapy depending on the severity, oral function, and progression of ALS. Therefore, we investigated the oral function and the necessity of PAP in patients with ALS who visited the Dental Division of the Center for Dysphagia in Tohoku University Hospital. Twenty-eight patients with ALS underwent various function examinations from July 2020 to June 2021. The analysis items included various oral function tests, the swallowing item of the Hyodo score, and whether PAP was needed. Twelve patients with limb onset and 16 with bulbar onset were enrolled. Five patients were diagnosed as requiring PAP. The patients who required PAP and those who did not were significantly different in the maximum tongue pressure and oral diadochokinesis (/ta/, /ka/). The need for PAP was closely related to tongue functions such as maximal tongue pressure and oral diadochokinesis (/ta/, /ka/). Conversely, it is essential to evaluate swallowing function, including the effect of PAP and ALS progression. [ABSTRACT FROM AUTHOR]

Copyright of Shipin Kexue/ Food Science is the property of Food Science Editorial Department and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Chinese as a Second Language Research is the property of De Gruyter and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Journal of Shaanxi University of Science & Technology is the property of Journal of Shaanxi University of Science & Technology Editorial Department and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Journal of Shaanxi University of Science & Technology is the property of Journal of Shaanxi University of Science & Technology Editorial Department and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

目的 探讨腹腔镜右半结肠癌术后胃瘫发生的影响因素。方法 选取470例右半结肠癌患者，均行右半 结肠完整结肠系膜切除术（CME），其中腹腔镜根治性右半结肠切除术 368例，腹腔镜根治性扩大右半结肠切除术 102例，观察术后胃瘫的发生情况，采用单因素和多因素回归分析影响胃瘫发生的影响因素。结果 470例患者中9 例发生术后胃瘫，发生率为1. 9%。单因素分析结果显示，年龄、围手术期血糖水平、焦虑自评量表评分及手术切除 范围与术后胃瘫发生有关（P 均<0. 05），而性别、手术时间、糖尿病、围手术期白蛋白水平与术后胃瘫发生无关（P 均>0. 05）。多因素 Logistic回归分析结果显示，年龄>70岁、围手术期血糖≥11. 1 mmol/L、焦虑自评量表评分≥50分 及根治性扩大右半结肠切除术是胃瘫发生的危险因素。结论 右半结肠癌术后胃瘫的发生与年龄、围手术期血糖 水平、焦虑自评量表评分及手术切除范围有关。 [ABSTRACT FROM AUTHOR]

Objective: To study the effects of Guizhi Fuling bolus combine with mifepristone on hemorheology, hemoglobin (Hb) and human epididymis protein 4 (HE4) in patients with hysteromyoma. Methods: 172 patients with hysteromyoma treated in 3201 Hospital Affiliated to Medical College of Xi'an Jiaotong University from March 2016 to May 2017 were selected, the patients were randomly divided into the observation group (n=86) and the control group (n=86). The control group was treated with mifepristone, the observation group was treated with Guizhi Fuling bolus on the basis of the control group, the efficacy was compared between the two groups after 3 months treatment, the Hb, HE4, myoma volume, blood rheology indexes were compared between the two groups before treatment and after 3 months treatment, the adverse reaction was compared between the two groups. Results: The total effective rate of the observation group was 97.67%, which was higher than 89.53%of the control group (P<0.05). After treatment, the levels of Hb in both groups were significantly higher than before treatment, which in the observation group was higher than the control group (P<0.05). The level of HE4 in both groups was lower than that before treatment, the observation group was lower than that in the control group (P<0. 05), and the fibroid volume was smaller than that before treatment, and the observation group was smaller than that in the control group (P<0.05). After treatment, the total blood viscosity (HBV), total blood viscosity (LBV), plasma viscosity (PV) and platelet aggregation rate (PAR) of the two groups were lower than before treatment, and the observation group was lower than the control group (P<0.05). The total incidence of adverse reactions in the observation group and control group were 13.95% and 10.47%, which was no significant difference (P>0.05). Conclusion: Guizhi poring bolus combined with mifepristone is effective in treating uterine fibroids, which can improve the level of hemorheology, Hb, HE4 and other indicators, with good safety and worth popularizing. [ABSTRACT FROM AUTHOR]

Copyright of Chinese Journal of Clinical Healthcare is the property of Chinese Journal of Clinical Healthcare and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

目的探讨中医禁食疗法对超重/肥胖2型糖尿病患者的临床疗效。方法本研究以超重/肥胖2型糖尿病患者为研究对象，使用中医禁食疗法治疗1周，对所有患者的临床疗效进行评估并随访6月。在禁食结束、禁食后3月、6月分别对糖化血红蛋白、空腹血糖、空腹胰岛素、HOMA-IR、体质量、BMI等指标进行检测。结果完成中医禁食疗法后随访3月和随访6月时，患者糖化血红蛋白均显著低于基线值水平（PPPP

Copyright of Chinese Journal of Clinical Healthcare is the property of Chinese Journal of Clinical Healthcare and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Journal of Engineering for Thermal Energy & Power / Reneng Dongli Gongcheng is the property of Journal of Engineering for Thermal Energy & Power and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Objective To evaluate early bone loss by radionuclide 99m Tc-MDP bone imaging and to intervene in early stage． Methods Early bone loss and osteoporosis models were produce in rabbits by intramuscular injection of dexamethasone sodium phosphate ( DX) and then a treatment was used on the model rabbits． The treatment drug 99Tc-MDP was injected once a week，up to 14 weeks． The ratio between region of interest ( ＲOI) site of radionuclide bone imaging and the fixed radioactive standard source ( ＲSF) ，bone histopathology，bone histomorphometry，bone mineral density，bone biomechanics，serum bone alkaline phosphatase ( BALP) ，osteocalcin ( BGP) ，and X ray and CT radiography of the lumbar vertebrae were determined，and the differences between the groups of were compared． Ｒesults After injection of different doses of DX on experimental rabbits，bone tissue pathological section，indexes of Bone morphological metrology，bone density，bone biomechanics，and BALP and BGP were used to confirm that the animal model was established successfully． After treatment for 14 weeks，early bone loss group showed that trabecular bone of the femoral head was arranged regularly and the trabecular bone was thickening comparing with those in the model group． However，the osteoporosis treatment group showed that trabecular bone was slightly sparse，and trabecular thickness was not uniform，but no fracture was found． The uptake of 99m Tc MDP bone scintigraphy agent in early bone loss model and osteoporosis bone tissue was significantly higher than that in control group ( P ＜ 0. 05) ，but the uptake of imaging agent in the treatment group was significantly decreased than the corresponding model group ( P ＜ 0. 05) ． Bone mineral density and bone histomorphometry were not significantly different between early bone loss treatment group and the control group ( P ＞ 0. 05) ． But the uptake of imaging agent in the early bone loss treatment group was significantly higher than that in the normal control group ( P ＜ 0. 05) ． Bone mineral density，bone biomechanics，and BALP and BGP were significantly different between bone osteoporosis therapy group and normal control group，and the greatest improvement was found in osteoporosis treatment group ( P ＜ 0. 05) ． Conclusion Ｒadionuclide “99m Tc-MDP”bone imaging can detect early bone loss in different individuals，and the effect of intervention on early bone loss stage is significantly better than that of severe osteoporosis． [ABSTRACT FROM AUTHOR]

Copyright of Chinese Journal of Osteoporosis is the property of Chinese Journal of Osteoporosis and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Chinese Journal of Osteoporosis is the property of Chinese Journal of Osteoporosis and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Chinese Journal of Osteoporosis is the property of Chinese Journal of Osteoporosis and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)